Form 8-K · Current report
Cencora 8-K, filed Oct 21, 2026
- Filed
- CIK
- 0001140859
- Accession no.
- 0001104659-26-117576
Summary
Cencora signed a definitive agreement to acquire American Oncology Network, a physician-led network of more than 350 oncology providers across 21 states, in a transaction valuing AON at $2.4 billion enterprise value, consisting of $2.3 billion at closing plus up to $100 million in contingent value rights. The deal, approved by AON's board on the recommendation of a special committee of independent directors, is subject to regulatory clearances and AON stockholder approval, and Cencora expects it to be accretive to adjusted diluted EPS in the second year after closing.
Key points
- Cencora holds approximately 4% of AON and expects to pay about $1.7 billion to raise its ownership to 75%, assuming certain AON stockholders roll over up to 25% of the company.
- Cencora announced updated fiscal year 2026 financial expectations and said it will discuss fiscal 2027 expectations on its fiscal fourth-quarter 2026 earnings call on November 4, 2026.
- Cencora CEO Robert P. Mauch said the acquisition expands its physician-led oncology MSO, and AON CEO Todd Schonherz said the agreement gives AON more resources and more time for patient care; AON's chief medical officer said the partnership will bolster its mission of delivering care in patients' own communities.
- Citi is lead financial advisor and J.P. Morgan Securities is also advising Cencora, while Moelis & Company is exclusive financial advisor to AON's special committee.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 21, 2026, Cencora, Inc., a Delaware corporation (the “Company”), announced updated fiscal year 2026 financial expectations and the transaction described in Item 7.01 below, pursuant to the news release described in Item 7.01 below. A copy of the news release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The updated financial expectations included in the news release described in Item 7.01 below are based on information available to Company management as of the date of the news release. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.